PB Fintech hits new low

PB Fintech, the parent of Policybazaar, remained under pressure after IRDAI’s proposed overhaul of insurance distribution economics raised concerns over commissions, revenue and earnings. The stock had crashed sharply on September 24, hitting a 52-week low at Rs.1115.10, after the regulator proposed tighter expense limits for insurers and product-wise commission caps for distributors.

Trigger

• IRDAI has proposed a new framework for insurance commissions and expense limits.
• Commission payouts may be linked to product type, distribution channel, policy size and effort involved in selling and servicing.
• The regulator has also proposed lowering expense-of-management limits for insurers over time.
• Analysts estimate that a 10% cut in new-business commission rates could reduce PB Fintech’s earnings by 10–12%.
• Non-life insurance, especially health and motor, could see a sharper impact than life insurance.
• The consultation process is still open; these are proposed rules, not final regulations yet.

The reason PB Fintech is reacting so sharply is simple: Policybazaar earns money by distributing insurance policies. If insurers are forced to reduce commissions or manage expenses more tightly, the amount paid to digital distributors can fall. That directly hurts PB Fintech’s revenue per policy sold.

The bigger worry is non-life insurance. Health and motor policies are large parts of online insurance distribution, and any cut in commissions can reduce the value of new business.

PB Fintech can try to cushion the impact by slowing hiring, cutting marketing spend and preserving cash. Since a large part of its platform cost is variable, there is some room to adjust expenses. But that also comes with a trade-off, lower marketing spend can slow customer acquisition and premium growth.

The caution is that this is still a regulatory paper, not a final rule. The final impact will depend on how much of the proposal is accepted, whether commission caps are softened, and whether PB Fintech can shift towards newer revenue models such as deeper insurer partnerships or MGA-style structures. For now, the market is treating this as a direct earnings risk, which is why the stock has seen such a sharp de-rating.